SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 12b-25
Notification of Late Filing
Commission File Number 333-57279
(Check one): [X] Form 10-K and Form 10-KSB [_] Form 11-K
[_] Form 20-F [_] Form 10-Q and Form 10-QSB
[_] Form N-SAR
For period ended December 31, 2000
Transition Report on Form 10-K and 10-KSB
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q and Form 10-QSB
Transition Report on Form N-SAR
For the transition period ended
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
Full name of registrant: Fountain View, Inc.
Former name if applicable:
Address of principal executive office (Street and Number)
2600 W. Magnolia Blvd.
City, State and Zip Code: Burbank, CA 91505-3031
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[_] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Forms 10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or
portion thereof will be filed on or
before the 15th calendar day following the prescribed due date;
or the subject quarterly report or transition report on
Form 10-Q, 10-QSB, or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date; and
[X] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III
NARRATIVE
We have not yet received a report from our actuaries regarding our Medical
Malpractice self-insurance exposure as of December 31, 2000. Consequently, our
independent auditors have not yet completed their audit. Once this report is
completed, we will be able to complete our financial statements and file our
annual report on Form 10-K for the year ended December 31, 2000.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Paul C. Rathbun (818) 841-8750
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or
15(d) or the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such report(s) been filed? If the answer is no, identify
report(s).
X Yes No
--- ---
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in
the subject report or portion thereof?
X Yes No
--- ---
The Registrant is awaiting on certain information to complete
the company's fiscal year end audit and depending upon the
outcome of the information, the results of the Registrant may
significantly change from prior fiscal year.
Fountain View, Inc.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: April 2, 2001 By: /s/ Paul C. Rathbun
--------------------------------------
Paul C. Rathbun, Chief Financial Officer
Ernst & Young LLP
725 South Figueroa Street
Los Angeles, CA 90017
April 2, 2001
Mr. Paul Rathbun
Chief Financial Officer
Fountain View, Inc.
2600 W. Magnolia Boulevard
Burbank, CA 91505-3031
Dear Mr. Rathbun:
In accordance with the notification to the Securities and Exchange Commission on
Form 12b-25 regarding Fountain View, Inc.'s inability to timely file its annual
report on Form 10-K for the year ended December 31, 2000, the factors described
in the succeeding paragraph make impossible the submission to our report as of a
date which will permit timely filing of your 2000 annual report to the
Commission.
We cannot issue our report because the Company's actuaries have not completed a
study of the Company's Medical Malpractice self-insured exposure, and it is not
expected that the actuarial report will be ready until after the 10-K reporting
deadline has passed.
You are authorized to attach a copy of this letter as an exhibit to Form 12b-25
to the Securities and Exchange Commission.
Very truly yours,
/s/ Ernst & Young LLP
---------------------------
Ernst & Young LLP